{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T22:44:17Z","timestamp":1782254657216,"version":"3.54.5"},"reference-count":50,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T00:00:00Z","timestamp":1657843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004686","name":"King Faisal University, Saudi Arabia","doi-asserted-by":"publisher","award":["GRANT894"],"award-info":[{"award-number":["GRANT894"]}],"id":[{"id":"10.13039\/501100004686","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Sofosbuvir is the first approved direct-acting antiviral (DAA) agent that inhibits the HCV NS5B polymerase, resulting in chain termination. The molecular models of the 2\u2032-dihalo ribonucleotides used were based on experimental biological studies of HCV polymerase inhibitors. They were modeled within HCV GT1a and GT1b to understand the structure\u2013activity relationship (SAR) and the binding interaction of the halogen atoms at the active site of NS5B polymerase using different computational approaches. The outputs of the molecular docking studies indicated the correct binding mode of the tested compounds against the active sites in target receptors, exhibiting good binding free energies. Interestingly, the change in the substitution at the ribose sugar was found to produce a mild effect on the binding mode. In detail, increasing the hydrophobicity of the substituted moieties resulted in a better binding affinity. Furthermore, in silico ADMET investigation implied the general drug likeness of the examined derivatives. Specifically, good oral absorptions, no BBB penetration, and no CYP4502D6 inhibitions were expected. Likely, the in silico toxicity studies against several animal models showed no carcinogenicity and high predicted TD50 values. The DFT studies exhibited a bioisosteric effect between the substituents at the 2\u2032-position and the possible steric clash between 2\u2032-substituted nucleoside analogs and the active site in the target enzyme. Finally, compound 6 was subjected to several molecular dynamics (MD) simulations and MM-PBSA studies to examine the protein-ligand dynamic and energetic stability.<\/jats:p>","DOI":"10.3390\/molecules27144530","type":"journal-article","created":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T01:53:22Z","timestamp":1658109202000},"page":"4530","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The Inhibitory Potential of 2\u2032-dihalo Ribonucleotides against HCV: Molecular Docking, Molecular Simulations, MM-BPSA, and DFT Studies"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3302-6253","authenticated-orcid":false,"given":"Ahmed","family":"Khalil","sequence":"first","affiliation":[{"name":"Department of Chemistry, College of Science, King Faisal University, Al Ahsa 31982, Saudi Arabia"},{"name":"Chemistry Department, Faculty of Science, Zagazig University, Zagazig 44519, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amany S.","family":"El-Khouly","sequence":"additional","affiliation":[{"name":"Department of Chemistry, College of Science, King Faisal University, Al Ahsa 31982, Saudi Arabia"},{"name":"Department of Chemistry, Faculty of Science, Tanta University, Tanta 31527, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2546-8035","authenticated-orcid":false,"given":"Eslam B.","family":"Elkaeed","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, College of Pharmacy, AlMaarefa University, Riyadh 13713, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6955-2263","authenticated-orcid":false,"given":"Ibrahim H.","family":"Eissa","sequence":"additional","affiliation":[{"name":"Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,7,15]]},"reference":[{"key":"ref_1","first-page":"47","article-title":"Chronic Hepatitis C Virus Infection: A Review of Current Direct-Acting Antiviral Treatment Strategies","volume":"9","author":"Zhang","year":"2016","journal-title":"Am. Chin. J. Med. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.2146\/ajhp140290","article-title":"Simeprevir and sofosbuvir for treatment of hepatitis C infection","volume":"72","author":"Chopp","year":"2015","journal-title":"Am. J. Health Pharm."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"14379","DOI":"10.1021\/acs.chemrev.6b00209","article-title":"Metabolism, Biochemical Actions, and Chemical Synthesis of Anticancer Nucleosides, Nucleotides, and Base Analogs","volume":"116","author":"Shelton","year":"2016","journal-title":"Chem. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"9154","DOI":"10.1021\/cr5002035","article-title":"Synthesis of Nucleoside Phosphate and Phosphonate Prodrugs","volume":"114","author":"Pradere","year":"2014","journal-title":"Chem. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ejmech.2013.09.047","article-title":"Design, synthesis and biological evaluation of phosphorodiamidate prodrugs of antiviral and anticancer nucleosides","volume":"70","author":"McGuigan","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4316","DOI":"10.1016\/j.bmcl.2009.05.122","article-title":"The phosphoramidate ProTide approach greatly enhances the activity of beta-2\u2032-C-methylguanosine against hepatitis C virus","volume":"19","author":"McGuigan","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"7202","DOI":"10.1021\/jm100863x","article-title":"Discovery of a beta-d-2\u2032-deoxy-2\u2032-alpha-fluoro-2\u2032-beta-C-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus","volume":"53","author":"Sofia","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1128\/AAC.00054-12","article-title":"Genotype and Subtype Profiling of PSI-7977 as a Nucleotide Inhibitor of Hepatitis C Virus","volume":"56","author":"Lam","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1128\/AAC.01262-12","article-title":"Pharmacokinetics, Safety, and Tolerability of GS-9851, a Nucleotide Analog Polymerase Inhibitor for Hepatitis C Virus, following Single Ascending Doses in Healthy Subjects","volume":"57","author":"Denning","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Ojima, I. (2009). Fluorine in Medicinal Chemistry and Chemical Biology, Wiley-Blackwell.","DOI":"10.1002\/9781444312096"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Brown, N. (2012). Bioisosterism in Medicinal Chemistry. Bioisosteres in Medical Chemistry, Wiley.","DOI":"10.1002\/9783527654307"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"115208","DOI":"10.1016\/j.bmc.2019.115208","article-title":"Synthesis and evaluation of 2\u2032-dihalo ribonucleotide prodrugs with activity against hepatitis C virus","volume":"28","author":"Krueger","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"126986","DOI":"10.1016\/j.bmcl.2020.126986","article-title":"Discovery of 2-aminoisobutyric acid ethyl ester (AIBEE) phosphoramidate prodrugs for delivering nucleoside HCV NS5B polymerase inhibitors","volume":"30","author":"Randolph","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1021\/acs.jmedchem.8b01300","article-title":"Discovery of a Series of 2\u2032-alpha-Fluoro,2\u2032-beta-bromo-ribonucleosides and Their Phosphoramidate Prodrugs as Potent Pan-Genotypic Inhibitors of Hepatitis C Virus","volume":"62","author":"Mengshetti","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.bmc.2019.01.005","article-title":"Synthesis and anti-HCV activity of beta-d-2\u2032-deoxy-2\u2032-alpha-chloro-2\u2032-beta-fluoro and beta-d-2\u2032-deoxy-2\u2032-alpha-bromo-2\u2032-beta-fluoro nucleosides and their phosphoramidate prodrugs","volume":"27","author":"Ovadia","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.1021\/acs.jmedchem.7b00067","article-title":"2\u2032-Chloro,2\u2032-fluoro Ribonucleotide Prodrugs with Potent Pan-genotypic Activity against Hepatitis C Virus Replication in Culture","volume":"60","author":"Zhou","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1016\/j.bmcl.2017.05.075","article-title":"Discovery of beta-d-2\u2032-deoxy-2\u2032-dichlorouridine nucleotide prodrugs as potent inhibitors of hepatitis C virus replication","volume":"27","author":"Pinho","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.1016\/j.bmcl.2017.10.024","article-title":"Synthesis and anti-HCV activity of a series of beta-d-2\u2032-deoxy-2\u2032-dibromo nucleosides and their corresponding phosphoramidate prodrugs","volume":"27","author":"Chen","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1126\/science.1259210","article-title":"Viral replication. Structural basis for RNA replication by the hepatitis C virus polymerase","volume":"347","author":"Appleby","year":"2015","journal-title":"Science"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1021\/ci4003969","article-title":"Detailed Computational Study of the Active Site of the Hepatitis C Viral RNA Polymerase to Aid Novel Drug Design","volume":"53","author":"Barakat","year":"2013","journal-title":"J. Chem. Inf. Model."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Kramer, M., Halleran, D., Rahman, M., Iqbal, M., Anwar, M.I., Sabet, S., Ackad, E., and Yousef, M.S. (2014). Comparative molecular dynamics simulation of Hepatitis C Virus NS3\/4A protease (Genotypes 1b, 3a and 4b) predicts conformational instability of the catalytic triad in drug resistant strains. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0104425"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1021\/jm400317w","article-title":"Discovery of a Potent Boronic Acid Derived Inhibitor of the HCV RNA-Dependent RNA Polymerase","volume":"57","author":"Maynard","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nrd1032","article-title":"ADMET in silico modelling: Towards prediction paradise?","volume":"2","author":"Gifford","year":"2003","journal-title":"Nat. Rev. Drug. Discov."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Smith, D.A., Allerton, C., Kalgutkar, A.S., and Walker, D.K. (2012). Pharmacokinetics and Metabolism in Drug Design, Wiley. [3rd ed.].","DOI":"10.1002\/9783527645763"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0928-0987(02)00219-1","article-title":"ADME evaluation: 2. A computer model for the prediction of intestinal absorption in humans","volume":"17","author":"Klopman","year":"2002","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1747-0285.2009.00791.x","article-title":"QSAR Studies of CYP2D6 Inhibitor Aryloxypropanolamines Using 2D and 3D Descriptors","volume":"73","author":"Roy","year":"2009","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_27","first-page":"21","article-title":"QSAR Models for the Prediction of Plasma Protein Binding","volume":"3","author":"Amin","year":"2013","journal-title":"BioImpacts"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1021\/jm0303195","article-title":"Classification of Kinase Inhibitors Using a Bayesian Model","volume":"47","author":"Xia","year":"2004","journal-title":"J. Med. Chem."},{"key":"ref_29","unstructured":"BIOVIA (2022, May 11). QSAR, Admet and Predictive Toxicology. Available online: https:\/\/www.3ds.com\/products-services\/biovia\/products\/molecular-modeling-simulation\/biovia-discovery-studio\/qsar-admet-and-predictive-toxicology\/."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Venkatapathy, R., Wang, N.C.Y., Martin, T.M., Harten, P.F., and Young, D. (2009). Structure-Activity Relationships for Carcinogenic Potential. General Applied and System Toxicology, Wiley.","DOI":"10.1002\/9780470744307.gat079"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1539-6924.1992.tb00709.x","article-title":"Comparison of the dependence of the TD50 on maximum tolerated dose for mutagens and nonmutagens","volume":"12","author":"Goodman","year":"1992","journal-title":"Risk Anal."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1539-6924.1993.tb00738.x","article-title":"An Overview of the Report: Correlation Between Carcinogenic Potency and the Maximum Tolerated Dose: Implications for Risk Assessment","volume":"13","author":"Krewski","year":"1993","journal-title":"Risk Anal."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/978-1-4939-3609-0_9","article-title":"In Silico Models for Repeated-Dose Toxicity (RDT): Prediction of the No Observed Adverse Effect Level (NOAEL) and Lowest Observed Adverse Effect Level (LOAEL) for Drugs","volume":"1425","author":"Pizzo","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1021\/ci049903s","article-title":"Assessment of the Oral Rat Chronic Lowest Observed Adverse Effect Level Model in TOPKAT, a QSAR Software Package for Toxicity Prediction","volume":"44","author":"Venkatapathy","year":"2004","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/qsar.200710103","article-title":"A Review of (Q)SAR Models for Skin and Eye Irritation and Corrosion","volume":"27","author":"Saliner","year":"2007","journal-title":"QSAR Comb. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Putz, M.M.D. (2013). Biological Activity and Toxicity: A Conceptual DFT Approach. Applications of Density Functional Theory to Biological and Bioinorganic Chemistry, Springer.","DOI":"10.1007\/978-3-642-32750-6"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1063\/1.475149","article-title":"Natural steric analysis: Ab initio van der Waals radii of atoms and ions","volume":"107","author":"Badenhoop","year":"1997","journal-title":"J. Chem. Phys."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"7368","DOI":"10.1021\/jo034808o","article-title":"Fast Calculation of van der Waals Volume as a Sum of Atomic and Bond Contributions and Its Application to Drug Compounds","volume":"68","author":"Zhao","year":"2003","journal-title":"J. Org. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/17460441.2018.1403419","article-title":"Molecular dynamics simulations and novel drug discovery","volume":"13","author":"Liu","year":"2017","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0959-440X(02)00308-1","article-title":"Molecular dynamics simulations","volume":"12","author":"Hansson","year":"2002","journal-title":"Curr. Opin. Struct. Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/267585a0","article-title":"Dynamics of folded proteins","volume":"267","author":"McCammon","year":"1977","journal-title":"Nature"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1021\/ct400314y","article-title":"Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 2. Explicit Solvent Particle Mesh Ewald","volume":"9","author":"Poole","year":"2013","journal-title":"J. Chem. Theory Comput."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s12013-019-00867-4","article-title":"Comparative Molecular Field Analysis and Molecular Docking Studies on Quinolinone Derivatives Indicate Potential Hepatitis C Virus Inhibitors","volume":"77","author":"Malathi","year":"2019","journal-title":"Cell Biophys."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"084904","DOI":"10.1063\/1.4986552","article-title":"Lubricant shear thinning behavior correlated with variation of radius of gyration via molecular dynamics simulations","volume":"147","author":"Liu","year":"2017","journal-title":"J. Chem. Phys."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1039\/C3MB70537D","article-title":"Molecular docking and molecular dynamics studies on beta-lactamases and penicillin binding proteins","volume":"10","author":"Kumar","year":"2014","journal-title":"Mol. Biosyst."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/jccs.201900148","article-title":"Assessing the performance of the g_mmpbsa tools to simulate the inhibition of oseltamivir to influenza virus neuraminidase by molecular mechanics Poisson\u2013Boltzmann surface area methods","volume":"67","author":"Ren","year":"2019","journal-title":"J. Chin. Chem. Soc."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1631243","DOI":"10.1155\/2020\/1631243","article-title":"Screening of Some Sulfonamide and Sulfonylurea Derivatives as Anti-Alzheimer\u2019s Agents Targeting BACE1 and PPAR\u03b3","volume":"2020","author":"Li","year":"2020","journal-title":"J. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.molstruc.2018.04.010","article-title":"Synthesis, docking, QSAR, ADMET and antimicrobial evaluation of new quinoline-3-carbonitrile derivatives as potential DNA-gyrase inhibitors","volume":"1166","author":"Saad","year":"2018","journal-title":"J. Mol. Struct."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"100008","DOI":"10.1063\/1.5133601","article-title":"Survey of the scoring functions for protein-ligand docking","volume":"2172","author":"Sapundzhi","year":"2019","journal-title":"AIP Conf. Proc."},{"key":"ref_50","unstructured":"Frisch, M.J., Schlegel, H.B., Scuseria, G.E., Robb, M.A., Cheeseman, J.R., Scalmani, G., Barone, V., Mennucci, B., Petersson, G.A., and Nakatsuji, H. (2013). Gaussian 09, Revision D.01, Gaussian, Inc."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/27\/14\/4530\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:51:19Z","timestamp":1760140279000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/27\/14\/4530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,15]]},"references-count":50,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["molecules27144530"],"URL":"https:\/\/doi.org\/10.3390\/molecules27144530","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,15]]}}}